News Headlines Article

FTC wants a ban on ‘pay-to-delay’ drug settlements
USA Today - Matthew Perrone, Associated Press

The Federal Trade Commission says patent settlements between drugmakers that cost U.S. consumers billions each year are on the rise. The agency reported Wednesday that the number of lucrative settlements between brand-name and generic drug companies rose to 19 last year from 16 in 2008 and 14 the year before.